Personal information

No personal information available

Activities

Collapse all

Employment (1)

Gustave Roussy: Villejuif, Île-de-France, FR

2008-11-02 to present | MD, PhD (Department of oncology for child and adolescent)
Employment
Source: Self-asserted source
Nathalie Gaspar

Works (13)

Role of 18F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?

British Journal of Cancer
2024-11-30 | Journal article
DOI: 10.1038/s41416-024-02864-8
Contributors: Nina Jehanno; Nadège Corradini; Nathalie Gaspar; Mehdi Brahmi; Thibaud Valentin; Gabriel Revon Rivière; Cyril Lervat; Jamie Probert; Natacha Entz-Werle; Ludovic Mansuy et al.
Source: check_circle
Crossref

Is rare cancer care organized at national health system level? Multiple case study in six EU countries

European Journal of Public Health
2022-11-29 | Journal article
DOI: 10.1093/eurpub/ckac166
Contributors: Joan Prades; Annalisa Trama; Paolo G Casali; Jean-Francois Emile; Nathalie Gaspar; Ramunas Janavicius; Rasa Jančiauskienė; Sakari Karjalainen; Katerina Kopeckova; Liisa Pylkkänen et al.
Source: check_circle
Crossref

Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas

Cancers
2022-03 | Journal article | Author
DOI: 10.3390/cancers14061482
Contributors: Charlotte Nazon; Marina Pierrevelcin; Thibault Willaume; Benoît Lhermitte; Noelle Weingertner; Antonio Di Marco; Laurent Bund; Florence Vincent; Guillaume Bierry; Anne Gomez-Brouchet et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Pediatric Cancer Data Commons: Federating and Democratizing Data for Childhood Cancer Research

JCO Clinical Cancer Informatics
2021-12 | Journal article
DOI: 10.1200/CCI.21.00075
Contributors: Alejandro Plana; Brian Furner; Monica Palese; Nicole Dussault; Suzi Birz; Luca Graglia; Maura Kush; James Nicholson; Stefanie Hecker-Nolting; Nathalie Gaspar et al.
Source: check_circle
Crossref

OLIE, ITCC-082: A Phase II Trial of Lenvatinib Plus Ifosfamide and Etoposide in Relapsed/Refractory Osteosarcoma

Future Oncology
2021-11 | Journal article
DOI: 10.2217/fon-2021-0743
Contributors: Nathalie Gaspar; Quentin Campbell-Hewson; Jie Huang; Chinyere E Okpara; Francisco Bautista
Source: check_circle
Crossref

Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma

Cancers
2021-11-22 | Journal article
DOI: 10.3390/cancers13225869
Contributors: Adèle Mangelinck; Nadia Habel; Audrey Mohr; Nathalie Gaspar; Bojana Stefanovska; Olivia Fromigué
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)☆

ESMO Open
2021-10 | Journal article
DOI: 10.1016/j.esmoop.2021.100250
Contributors: N. Gaspar; Q. Campbell-Hewson; S. Gallego Melcon; F. Locatelli; R. Venkatramani; S. Hecker-Nolting; M. Gambart; F. Bautista; E. Thebaud; I. Aerts et al.
Source: check_circle
Crossref

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?

Cancers
2021-04 | Journal article | Author
DOI: 10.3390/cancers13071683
Contributors: Eric Thebault; Sophie Piperno-Neumann; Diep Tran; Hélène Pacquement; Perrine Marec-Berard; Cyril Lervat; Marie-Pierre Castex; Morgane Cleirec; Emmanuelle Bompas; Jean-Pierre Vannier et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?

Cancers
2021-01-23 | Journal article
DOI: 10.3390/cancers13030423
Contributors: Anne Gomez-Brouchet; Julia Gilhodes; Nathalie Van Acker; Regis Brion; Corinne Bouvier; Pauline Assemat; Nathalie Gaspar; Sebastien Aubert; Jean-Marc Guinebretiere; Beatrice Marie et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice

Cancers
2019-07-17 | Journal article
DOI: 10.3390/cancers11070997
Contributors: Maria Eugénia Marques da Costa; Antonin Marchais; Anne Gomez-Brouchet; Bastien Job; Noémie Assoun; Estelle Daudigeos-Dubus; Olivia Fromigué; Conceição Santos; Birgit Geoerger; Nathalie Gaspar
Source: check_circle
Crossref

Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice

Cancer Medicine
2018-03 | Journal article
DOI: 10.1002/cam4.1346
Contributors: Maria Eugenia Marques da Costa; Estelle Daudigeos‐Dubus; Anne Gomez‐Brouchet; Olivia Bawa; Valerie Rouffiac; Massimo Serra; Katia Scotlandi; Conceição Santos; Birgit Geoerger; Nathalie Gaspar
Source: check_circle
Crossref

Quelle démarche d’éducation thérapeutique (ETP) pour les adolescents et jeunes adultes atteints de cancer ? Expérience du groupe ETP de « Go-AJA »

Bulletin du Cancer
2016-12 | Journal article
DOI: 10.1016/j.bulcan.2016.10.006
Contributors: Nadège Corradini; Loïc Dagorne; Marielle Retailleau; Françoise Rédini; Hélène Sudour-Bonnange; Leila Gofti-Laroche; Anne Le Rhun; Nathalie Gaspar
Source: check_circle
Crossref

Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group

European Journal of Cancer
2016-07 | Journal article
DOI: 10.1016/j.ejca.2016.03.075
Contributors: Stéphanie Foulon; Bernadette Brennan; Nathalie Gaspar; Uta Dirksen; Lee Jeys; Anna Cassoni; Line Claude; Beatrice Seddon; Perrine Marec-Berard; Jeremy Whelan et al.
Source: check_circle
Crossref

Peer review (4 reviews for 4 publications/grants)

Review activity for British journal of cancer. (1)
Review activity for Bulletin du cancer. (1)
Review activity for Molecular imaging and biology (1)
Review activity for Nature communications (1)
How many people are using ORCID?